CD34 and hepatoblastoma: Despite these difficulties, we recently identified a CD34+OV-6+CD90+csVimentin+ population in hepatoblastoma cell lines, which showed CSC characteristics and susceptibility to the Hsp90 inhibitor 17-AAG [16].